March 2022

Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Annora is committed to provide medicines with highest quality, safety and efficacy that meets the customer, applicable statutory and regulatory requirements.

BDR Group of companies has grown steadily and become a house-hold name in the pharmaceutical Industry over the last 15 years, in both domestic and international arenas. We are recognized as a niche player in manufacturing of Pharmaceutical APIs and for our renowned new age formulations. The group is complemented majorly by its two companies - BDR Pharmaceuticals International Pvt Ltd and BDR Life sciences Pvt. Ltd, each one having stamped its own supremacy in respective fields, i.e. API and formulation manufacturing, respectively.

As per the Orders of the Collector and District Magistrate, Nellore, Applications in the prescribed proforma are invited from the eligible candidates for recruitment of posts noted in the annexure on contract basis Under National Health Mission Programme, SPSR Nellore District. The Applicants can download the Application & the details of vacancies available & eligibility particulars through Website address.

Post : Pharmacist Gr- II

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement (DGR) and Kendriya Sainik Board (KSB).

Trueosis ever since its inception in 2007 has been involved in providing high quality manpower solutions and services. We have been successful in providing consistent and reliable services to our customers who include BFSI, BPOs, ITIndustries, Pharma, Private Manufacturing Enterprises and FMCG.

Post : Medical Representative

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar.

Post : Executive Trainee / Executive / Senior Executive / Junior Manager – FR&D

Hetero is a globally renowned vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 27+ years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services.

PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a broad range of therapeutic areas to the worldwide pharmaceutical, biotechnology and medical device industries.

Post : Sr Data Support Specialist, R&A

Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

Post : Operator/ Sr. Operator /Officer/ Jr. Executive

Delhi Pharmaceutical Sciences and Research University (DPSRU), is the first Pharmacy University of India established by an Act7 of 2008 of State Legislature of Delhi as a State University vide Notification No.F. 2(412)/2008/SB/Vol. II/71 dated 21.01.2010 and is empowered to award degrees as specified by the UGC under section 22 of the UGC Act 1956 through its own departments and constituent colleges in regular mode vide notification No. F.9-19/2015/(CPP-I/PU) dated 22nd September 2015.